CNC
FY2026 Q1 · Calendar Q2 2026
Centene Corp.
Centene delivered a decisive Q1 2026 beat, with adjusted EPS of $3.37 versus $2.23 estimated and revenue of $49.9 billion versus $47.5 billion estimated. The company raised full-year adjusted EPS guidance to above $3.40, driven by Medicaid health benefit ratio improvement to 93.1%, Medicare Advantage and Part D outperformance, and Marketplace pretax margins near 3%. Management expressed confidence in trend-management initiatives and AI-enabled analytics as margin-recovery levers, while acknowledging that final risk-adjustment outcomes and elevated medical cost trends remain key variables. The stock surged 14.4% on the report and has continued to drift higher.
EPS surprise+51.1%
Market move+14.0%
